Bioventus (BVS) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Bioventus (BVS) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 16.91% |
| 10 | Bioventus | 967.47 Mn | 938.02 Mn | 105.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -70.09% |
| Mar 28, 2026 | 64.37% |
| Dec 31, 2025 | 263.97% |
| Sep 27, 2025 | 1,513.50% |
| Jun 28, 2025 | 380.95% |
| Mar 29, 2025 | 30.48% |
| Dec 31, 2024 | 443.24% |
| Sep 28, 2024 | -2.20% |
| Jun 29, 2024 | -402.34% |
| Mar 30, 2024 | 189.30% |
| Dec 31, 2023 | 103.76% |
| Sep 30, 2023 | 100.02% |
| Jul 1, 2023 | 102.07% |
| Apr 1, 2023 | 72.61% |
| Dec 31, 2022 | -10.67% |
| Oct 1, 2022 | -361,604.88% |
| Jul 2, 2022 | -4,446.89% |
| Apr 2, 2022 | -154.74% |
| Dec 31, 2021 | -191.62% |
| Oct 2, 2021 | -101.62% |